drug · small molecule
patient view →levosimendan
Phase 3updated 2mo agoby $TENX TENAX THERAPEUTICS, INC.🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for congestive heart failure and cardiovascular disease and 12 investigational indications.
targets
Phosphodiesterase 3Troponin, cardiac muscle
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that